Perioperative measurements of interleukin-6 and α-melanocyte-stimulating hormone in cardiac transplant patients

T. Sakai, T. W. Latson, C. W. Whitten, W. S. Ring, J. M. Lipton, A. H. Giesecke, D. N. O'Flaherty

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Interleukin-6 (IL-6) and α-melanocyte-stimulating hormone (αMSH) are important modulators of the immunologic response to tissue injury and antigenic challenge. Serial changes in the plasma concentrations of these two peptides were measured in 12 patients undergoing heart transplantation. Tissue concentrations of IL-6 in atrial samples from both donor and recipient hearts were also compared. Plasma IL-6 concentration remained stable prior to cardiopulmonary bypass (CPB), initially decreased with the onset of CPB, and then increased significantly over control values at the end of CPB (180 ± 40 v 53 ± 60 pg/mL). Plasma IL-6 remained elevated for at least 60 minutes after CPB, and then it returned to control values by 24 hours postoperatively (67 ± 9 pg/mL). Examination of IL-6 changes after CPB in 10 additional patients undergoing nontransplant cardiac surgery with CPB revealed a similar elevation in IL-6 at 60 minutes after CPB (290 ± 76 pg/mL). However, IL-6 in the nontransplant group remained significantly elevated at 24 hours (138 ± 42 pg/mL). These combined results suggest that CPB causes a marked increase in IL-6, and that implantation of a new heart in transplant patients does not augment this increase. The return of IL-6 to control values by 24 hours in the patients who have had transplants suggests that immunosuppression has an appreciable effect on IL-6 at this time. In contrast to IL-6, plasma αMSH never increased above control values. The absence of a significant change in αMSH suggests that there is no interaction between these two immunologic modulators under the conditions of this study. Tissue IL-6 in hearts with idiopathic cardiomyopathy was significantly less than that in other hearts (ie, donor hearts and hearts with ischemic cardiomyopathy). Additional studies are required to determine if this reduced tissue concentration of IL-6 is related to the cardiomyopathic process.

Original languageEnglish (US)
Pages (from-to)17-22
Number of pages6
JournalJournal of Cardiothoracic and Vascular Anesthesia
Volume7
Issue number1
DOIs
StatePublished - 1993

Fingerprint

Melanocyte-Stimulating Hormones
Interleukin-6
Transplants
Cardiopulmonary Bypass
Cardiomyopathies
Tissue Donors
Heart Transplantation
Immunosuppression
Thoracic Surgery

Keywords

  • cardiac surgery
  • cardiomyopathy
  • cardiopulmonary bypass
  • immune response

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Perioperative measurements of interleukin-6 and α-melanocyte-stimulating hormone in cardiac transplant patients. / Sakai, T.; Latson, T. W.; Whitten, C. W.; Ring, W. S.; Lipton, J. M.; Giesecke, A. H.; O'Flaherty, D. N.

In: Journal of Cardiothoracic and Vascular Anesthesia, Vol. 7, No. 1, 1993, p. 17-22.

Research output: Contribution to journalArticle

@article{3396a4a3a4fc4e8ab4fe415cda4131a7,
title = "Perioperative measurements of interleukin-6 and α-melanocyte-stimulating hormone in cardiac transplant patients",
abstract = "Interleukin-6 (IL-6) and α-melanocyte-stimulating hormone (αMSH) are important modulators of the immunologic response to tissue injury and antigenic challenge. Serial changes in the plasma concentrations of these two peptides were measured in 12 patients undergoing heart transplantation. Tissue concentrations of IL-6 in atrial samples from both donor and recipient hearts were also compared. Plasma IL-6 concentration remained stable prior to cardiopulmonary bypass (CPB), initially decreased with the onset of CPB, and then increased significantly over control values at the end of CPB (180 ± 40 v 53 ± 60 pg/mL). Plasma IL-6 remained elevated for at least 60 minutes after CPB, and then it returned to control values by 24 hours postoperatively (67 ± 9 pg/mL). Examination of IL-6 changes after CPB in 10 additional patients undergoing nontransplant cardiac surgery with CPB revealed a similar elevation in IL-6 at 60 minutes after CPB (290 ± 76 pg/mL). However, IL-6 in the nontransplant group remained significantly elevated at 24 hours (138 ± 42 pg/mL). These combined results suggest that CPB causes a marked increase in IL-6, and that implantation of a new heart in transplant patients does not augment this increase. The return of IL-6 to control values by 24 hours in the patients who have had transplants suggests that immunosuppression has an appreciable effect on IL-6 at this time. In contrast to IL-6, plasma αMSH never increased above control values. The absence of a significant change in αMSH suggests that there is no interaction between these two immunologic modulators under the conditions of this study. Tissue IL-6 in hearts with idiopathic cardiomyopathy was significantly less than that in other hearts (ie, donor hearts and hearts with ischemic cardiomyopathy). Additional studies are required to determine if this reduced tissue concentration of IL-6 is related to the cardiomyopathic process.",
keywords = "cardiac surgery, cardiomyopathy, cardiopulmonary bypass, immune response",
author = "T. Sakai and Latson, {T. W.} and Whitten, {C. W.} and Ring, {W. S.} and Lipton, {J. M.} and Giesecke, {A. H.} and O'Flaherty, {D. N.}",
year = "1993",
doi = "10.1016/1053-0770(93)90112-X",
language = "English (US)",
volume = "7",
pages = "17--22",
journal = "Journal of Cardiothoracic and Vascular Anesthesia",
issn = "1053-0770",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Perioperative measurements of interleukin-6 and α-melanocyte-stimulating hormone in cardiac transplant patients

AU - Sakai, T.

AU - Latson, T. W.

AU - Whitten, C. W.

AU - Ring, W. S.

AU - Lipton, J. M.

AU - Giesecke, A. H.

AU - O'Flaherty, D. N.

PY - 1993

Y1 - 1993

N2 - Interleukin-6 (IL-6) and α-melanocyte-stimulating hormone (αMSH) are important modulators of the immunologic response to tissue injury and antigenic challenge. Serial changes in the plasma concentrations of these two peptides were measured in 12 patients undergoing heart transplantation. Tissue concentrations of IL-6 in atrial samples from both donor and recipient hearts were also compared. Plasma IL-6 concentration remained stable prior to cardiopulmonary bypass (CPB), initially decreased with the onset of CPB, and then increased significantly over control values at the end of CPB (180 ± 40 v 53 ± 60 pg/mL). Plasma IL-6 remained elevated for at least 60 minutes after CPB, and then it returned to control values by 24 hours postoperatively (67 ± 9 pg/mL). Examination of IL-6 changes after CPB in 10 additional patients undergoing nontransplant cardiac surgery with CPB revealed a similar elevation in IL-6 at 60 minutes after CPB (290 ± 76 pg/mL). However, IL-6 in the nontransplant group remained significantly elevated at 24 hours (138 ± 42 pg/mL). These combined results suggest that CPB causes a marked increase in IL-6, and that implantation of a new heart in transplant patients does not augment this increase. The return of IL-6 to control values by 24 hours in the patients who have had transplants suggests that immunosuppression has an appreciable effect on IL-6 at this time. In contrast to IL-6, plasma αMSH never increased above control values. The absence of a significant change in αMSH suggests that there is no interaction between these two immunologic modulators under the conditions of this study. Tissue IL-6 in hearts with idiopathic cardiomyopathy was significantly less than that in other hearts (ie, donor hearts and hearts with ischemic cardiomyopathy). Additional studies are required to determine if this reduced tissue concentration of IL-6 is related to the cardiomyopathic process.

AB - Interleukin-6 (IL-6) and α-melanocyte-stimulating hormone (αMSH) are important modulators of the immunologic response to tissue injury and antigenic challenge. Serial changes in the plasma concentrations of these two peptides were measured in 12 patients undergoing heart transplantation. Tissue concentrations of IL-6 in atrial samples from both donor and recipient hearts were also compared. Plasma IL-6 concentration remained stable prior to cardiopulmonary bypass (CPB), initially decreased with the onset of CPB, and then increased significantly over control values at the end of CPB (180 ± 40 v 53 ± 60 pg/mL). Plasma IL-6 remained elevated for at least 60 minutes after CPB, and then it returned to control values by 24 hours postoperatively (67 ± 9 pg/mL). Examination of IL-6 changes after CPB in 10 additional patients undergoing nontransplant cardiac surgery with CPB revealed a similar elevation in IL-6 at 60 minutes after CPB (290 ± 76 pg/mL). However, IL-6 in the nontransplant group remained significantly elevated at 24 hours (138 ± 42 pg/mL). These combined results suggest that CPB causes a marked increase in IL-6, and that implantation of a new heart in transplant patients does not augment this increase. The return of IL-6 to control values by 24 hours in the patients who have had transplants suggests that immunosuppression has an appreciable effect on IL-6 at this time. In contrast to IL-6, plasma αMSH never increased above control values. The absence of a significant change in αMSH suggests that there is no interaction between these two immunologic modulators under the conditions of this study. Tissue IL-6 in hearts with idiopathic cardiomyopathy was significantly less than that in other hearts (ie, donor hearts and hearts with ischemic cardiomyopathy). Additional studies are required to determine if this reduced tissue concentration of IL-6 is related to the cardiomyopathic process.

KW - cardiac surgery

KW - cardiomyopathy

KW - cardiopulmonary bypass

KW - immune response

UR - http://www.scopus.com/inward/record.url?scp=0027475598&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027475598&partnerID=8YFLogxK

U2 - 10.1016/1053-0770(93)90112-X

DO - 10.1016/1053-0770(93)90112-X

M3 - Article

C2 - 8381685

AN - SCOPUS:0027475598

VL - 7

SP - 17

EP - 22

JO - Journal of Cardiothoracic and Vascular Anesthesia

JF - Journal of Cardiothoracic and Vascular Anesthesia

SN - 1053-0770

IS - 1

ER -